| CXSL2500357 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products(3.3) | New Drug Application | 2025-05-08 | | Nanjing Zhengda Tianqing Pharmaceutical Co Ltd | | | view |
| CXSL2500356 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products(3.3) | New Drug Application | 2025-05-08 | | Nanjing Zhengda Tianqing Pharmaceutical Co Ltd | | | view |
| JYSB2500074 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2025-03-20 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2500071 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2025-03-20 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2500072 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2025-03-20 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2500073 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2025-03-20 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2500065 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products(1) | Supplementary Application | 2025-03-18 | | Roche Pharma (Schweiz) AG | | | view |
| JYSB2500066 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products(1) | Supplementary Application | 2025-03-18 | | Roche Pharma (Schweiz) AG | | | view |
| JYSB2500067 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products(1) | Supplementary Application | 2025-03-18 | | Roche Pharma (Schweiz) AG | | | view |
| JYSB2500064 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products(1) | Supplementary Application | 2025-03-18 | | Roche Pharma (Schweiz) AG | | | view |
| JYSZ2300016 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | License Renew | 2023-03-30 | | Roche Pharma (Schweiz) AG;Roche (China) Holding Ltd;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSZ2300017 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | License Renew | 2023-03-30 | | Roche Pharma (Schweiz) AG;Roche (China) Holding Ltd;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSZ2300015 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | License Renew | 2023-03-30 | | Roche Pharma (Schweiz) AG;Roche (China) Holding Ltd;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSZ2300018 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | License Renew | 2023-03-30 | | Roche Pharma (Schweiz) AG;Roche (China) Holding Ltd;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2300047 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2023-03-08 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2300045 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2023-03-08 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2300046 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2023-03-08 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2300048 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2023-03-08 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| CXSL2300015 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products(3.3) | New Drug Application | 2023-01-06 | | Nanjing Zhengda Tianqing Pharmaceutical Co Ltd | | | view |
| JYSB2200167 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2022-08-30 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
